Literature DB >> 25017667

Total knee arthroplasty in carefully selected patients aged 80 years or older.

Feng-Chih Kuo, Chi-Hsiang Hsu, Wun-Schen Chen, Jun-Wen Wang.   

Abstract

BACKGROUND: The patients aged ≥ 80 years have been considered to have a higher risk of mortality, postoperative complications, and longer hospital stay following total knee arthroplasty (TKA) than younger patients. The purposes of this retrospective study were to review the results of TKA in patients aged ≥ 80 years after a preoperative consultation.
METHODS: Seventy-five patients aged ≥ 80 years underwent TKA from January 2006 and June 2010. A control group of younger patients (65-74 years) was matched in a 1:1 ratio with the ≥ 80 years group for sex, diagnosis of the disease, body mass index, the American Society of Anesthesiologists' type of anesthesia, and comorbidities. Cardiologists and neurologists carefully evaluated the risk of patients for both groups before surgery. The groups were compared with regard to Knee Society Scores, Knee Society Function Score, Western Ontario and McMaster Universities Osteoarthritis Index scores, length of stay, postoperative complications, and 90-day mortality rate.
RESULTS: The mean follow-up was 2.3 years (range 1-5 years). We found no difference in the functional outcomes and length of stay between the two groups. The ≥ 80 years group had a higher rate of blood transfusion (29.3% versus 10.7%, p = 0.006) after Bonferroni correction. There were no cardiovascular or cerebrovascular complications in the ≥ 80 years group. There were no mortalities within 90 days in either group.
CONCLUSIONS: Despite similar functional results and pain relief of the TKA compared with the young patient group, the ≥ 80 years group had a higher complication rate of blood transfusion. With a preoperative consultation by cardiologists and neurologists, patients aged ≥ 80 years have a low cardiovascular or cerebrovascular complications and 90-day mortality after TKA.

Entities:  

Mesh:

Year:  2014        PMID: 25017667      PMCID: PMC4131159          DOI: 10.1186/s13018-014-0061-z

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


Background

Total knee arthroplasty (TKA) is an effective surgical intervention, which alleviates pain and improves function and health-related quality of life in patients with late-stage arthritis of the knee joint [1],[2]. With improvements in anesthesia, general health care, and surgical techniques, this procedure has become widely accepted for use in very elderly patients, including those more than 80 years old. However, a recent study showed that despite similar pain relief and functional improvement, compared with a younger group of patients, octogenarian had a higher risk of death, postoperative complications and longer hospital stay after standard TKA [3]. The purpose of this retrospective study was to compare clinical functional outcomes, postoperative complications, length of stay, and 90-day mortality after TKA between patients aged ≥80 years and a younger patient group.

Methods

We performed a retrospective case-controlled study with a one-to-one ratio of cases and matched controls. Using our institutional total joint registry database, we identified all patients who were aged 80 years or older undergoing primary total knee arthroplasty at our institution from January 2006 and June 2010. One thousand twenty-four patient (1,186 TKAs) total knee arthroplasty procedures were performed during the study period. We designed a standard protocol for patients aged ≥65 years before they underwent major orthopedic surgery including TKA at our institution. Routine preoperative consultation with cardiologists and neurologists were conducted for these patients who were willing to undergo a TKA. The cardiologist evaluated these patients based on the American Heart Association (AHA) guidelines on perioperative cardiovascular evaluation and care for patients undergoing noncardiac surgery [4]. The cardiologist would use these interventions, including a 12-lead electrocardiogram (ECG), exercise stress test, noninvasive stress test (thallium-201 myocardial perfusion scintigraphy), or echocardiography to predict perioperative cardiovascular risk. If the perioperative cardiovascular risk was high (>5%), surgery was not recommended. If the perioperative cardiovascular risk was low (<5%), the patient was going to have surgery. The neurologist used duplex ultrasounds to evaluate the carotid and vertebrobasilar artery stenosis to predict the risk of perioperative stroke [5],[6]. Patients with symptomatic carotid bruits or a history of stroke or transient ischemic attack and a documented stenosis of >50% may have a risk for stroke as high as 3.6% [7]. Therefore, surgery was not recommended. During the study period, 103 patients aged 80 years or older were referred to cardiologists and neurologists for preoperative consultation. Twenty-eight of these patients (27%) were not considered for surgery because of high risk of perioperative cardiovascular and cerebrovascular disease. Therefore, 75 patients aged 80 years or older were enrolled to the study. For each patient aged 80 years or older, we aimed to identify one matching patient aged between 65 and 74 years as a control. This control population was derived with use of our electronic database by matching for the following variables: sex, diagnosis of the disease, body mass index (BMI), American Society of Anesthesiologists (ASA), type of anesthesia (regional or general), and comorbidities. Matched variables were chosen to eliminate their potential confounding effects on study outcomes. The exclusion criteria were bilateral total knee arthroplasty and less than 6 months of follow-up after the procedure of interest. This study was approved by the institutional review board of Chang Gung Memorial Hospital (IRB No.: 101-3512B). Demographic data, including age, sex, BMI, knee disease (osteoarthritis, rheumatoid arthritis, or post-traumatic arthritis), ASA, type of anesthesia (general or spinal), preoperative hemoglobin (Hb) and hematocrit (Hct) levels, total 48-h postoperative tube drainage, wound length, and length of stay, were recorded. Other preoperative comorbidities were also recorded: diabetes mellitus, cardiac disease (hypertension, CAD, congestive heart failure, and arrhythmia), renal insufficiency, liver cirrhosis, chronic obstructive pulmonary disease (COPD), adrenocortical insufficiency, peptic ulcer, gout, and coagulopathy.

Surgical technique

All operations were performed or supervised by the senior author (JWW) and employed the mini-midvastus approach for TKA, as described by Haas et al.: ‘The skin incision was made along the medial aspect of the patella to the medial border of the mid-to-distal tibial tubercle [8]. The vastus medialis oblique muscle was split approximately 2 cm in line with its fibers from the superior medial pole of the patella.’ All TKAs were unilateral and cemented, and the same prosthesis was used (Nex-Gen, Legacy Posterior Stabilized Prosthesis; Zimmer, Warsaw, IN, USA). We used an intramedullary alignment rod for femoral cutting and an extramedullary guide system for tibial cutting. The femoral canal for intramedullary guiding was routinely plugged with bone. Meticulous electric cauterization of the soft tissue bleeding points was performed throughout the surgery. The tourniquet was not released until skin closure and application of a compressive dressing. Intraoperative blood loss was negligible in all patients because the tourniquet was not deflated until wound closure. A drain was put in the knee joint before wound closure.

Postoperative care

A standard postoperative rehabilitation protocol, including continuous passive motion of the knee and muscle strengthening exercise immediately after returning to the ward, was followed in both groups. All patients were asked to get out of bed with walker support on the afternoon of the first postoperative day to prevent deep-vein thrombosis (DVT), as described by Pearse [9]. We subcutaneously administered 20 mg enoxaparin (Clexane; Glaxo-Smith-Kline, Brentford, Middlesex, UK) in all patients as postoperative prophylaxis for DVT every 12 h until discharge. Then, they received indomethacin (orally or by suppository) for at least 4 weeks [10]. All patients returned to the clinic 2 weeks after surgery for suture removal and clinical examination, at 6 weeks for clinical evaluation of functional recovery, and at 12 weeks for radiographic examination of the knee. Partial weight bearing with a cane support usually was allowed 4–6 weeks after surgery, and full weight bearing without a support usually was allowed 6–12 weeks after surgery. We applied the principle of the criteria and guidelines for perioperative transfusion suggested by the National Institutes of Health Consensus Conference, which state that the decision to transfuse blood depends on clinical assessment, aided by laboratory data, relevant to symptoms and signs of acute anemia [11]. DVT was suspected in the presence of swelling or edema of the thigh or calf, greater than 3 cm, compared to the contralateral leg with calf tenderness for as long as 12 weeks after the operation. We did not routinely screen for venous thrombosis, but all clinically suspected thrombosis or pulmonary embolisms (PEs) were investigated using antegrade venography or CT of the chest. Patients were assessed using the Knee Society Scores (KSS), the Knee Society Function Score (KSFS), the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores, and range of knee motion (ROM) before operation and at the latest follow-up. Radiographic evaluation included standing anteroposterior radiographs of the knee and a long weight-bearing film of the limb to measure the tibiofemoral mechanical axis (TFM) before operation and at the latest follow-up. A postoperative outlier was defined if there was >3° deviation from the ideal (TFM = 0°). We obtained data regarding medical complications (confusion, pneumonia, myocardial infarction [MI], DVT with positive venogram finding, transfer to intensive care unit, postoperative congestive heart failure [CHF], pulmonary embolism, upper gastrointestinal [UGI] bleeding, cerebral vascular accident/transient ischemic accident (CVA/TIA), postoperative anemia, and atelectasis) and surgical complications (hematoma around the knee, superficial wound infection) within 90 days after operation. We also ascertained the 90-day postoperative mortality. Other complications, including periprosthetic fractures around the knee, deep infection or loosening of the implant were recorded.

Statistical analysis

All statistical comparisons were made using Statistical Package for Social Sciences (SPSS) software (version 15; Chicago, IL, USA). A sample size of 150 patients achieves 85% power to detect an effect size (W) of 0.2513 using a 1 degree of freedom chi-square test with a significance level (alpha) of 0.05000. We compared differences in age, BMI, wound length, length of stay, and preoperative Hb and Hct levels, tube drainage, mechanical axis, range of motion, and function scores (the KSS, the KSFS, and the WOMAC score) between two groups using independent t test. We compared difference in diagnosis, anesthesia type, ASA, preoperative comorbidity and postoperative complications using chi-square test or Fisher's exact test. A Bonferroni-adjusted significance level of 0.00416 was calculated to account for the increased possibility of a type-I error.

Results

The mean duration of follow-up was 2.3 years (range 1–5 years). The mean age at operation was 82 years (range 80–93 years) among the ≥80 years group and 72 years (range 65–74 years) among the controls. The two patient groups were similar with respect to sex, BMI, diagnosis, ASA, type of anesthesia (Table 1), mean preoperative KSS, KSFS, WOMAC score, preoperative ROM and knee alignment (TFM) (Table 2), and comorbidities (Table 3).
Table 1

Patients' characteristics

Parameters≥80 years groupControl group p value
Mean age (year)
82 (2.8; 80–93)
72 (2.2; 65 ~ 74)
<0.001
Female, n (%)
54 (72)
62 (82)
0.144
Mean BMI (kg/m2)
26.2 (3.0; 19.5–35.5)
28.2 (3.7; 21.5–38.9)
0.078
OA/RA/PTA, n
73/2/0
72/2/1
0.528
ASA risk, n (%)
 
 
0.1
 I
0
2 (2.7)
 
 II
42 (56)
50 (66.6)
 III
33 (44)
23 (30.7)
Anesthesia, n (%)
 
 
0.684
 General
73 (97.3)
72 (96)
 
 Spinal2 (2.7)3 (4)

Numbers in parenthesis are standard deviation and ranges. OA osteoarthritis, RA rheumatoid arthritis, PTA post-traumatic arthritis, ASA American Society of Anesthesiologist.

Table 2

Preoperative data

Parameter≥80 years group mean (SD; range)Control group mean (SD; range) p value
KSS, points
38 (7.1; 18–56)
40 (4.8; 30–52)
0.245
KSFS, points
42 (8.1; 20–60)
44 (5.0; 30–56)
0.645
WOMAC, points
76.2 (9.1; 54–88)
75.4 (7.8; 53–83)
0.557
TFM
11.9° varus (20.3° valgus to 29° varus)
9.4° varus (8° valgus to 29.8° varus)
0.936
ROM107° (20.9°; 35°–135°)113° (12.8°; 70°–135°)0.057

SD standard deviation, KSS Knee Society Score, KSFS Knee Society Function Score, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, TFM tibiofemoral mechanical axis, ROM range of knee motion.

Table 3

Prevalence of comorbidities

Comorbidity≥80 years groupControl group p value
DM
19
20
0.973
Cardiac
 
 
 
 Hypertension
52
53
0.82
 CAD
7
5
0.497
 CHF
2
1
0.614
 Arrhythmia
6
3
0.32
Liver cirrhosis
0
2
0.497
Renal insufficiency
4
4
0.951
Gout
2
3
0.684
COPD
5
7
0.598
Adrenocortical insufficiency
7
4
0.311
Peptic ulcer
13
11
0.575
Coagulopathy
0
2
0.497
Anemiaa
17
14
0.459
Hemoglobin (g/dL), mean (SD; range)
12.7 (1.7; 8.8 ~ 16.7)
13.2 (1.4; 9.8 ~ 16.9)
0.115
Hematocrit, mean (SD; range)39.1 (4.0; 30.5 ~ 48.1)40.2 (3.9; 30.3 ~ 49.9)0.082

DM diabetes mellitus, CAD coronary artery disease, CHF congestive heart failure, CVA cerebral vascular accident, COPD chronic obstructive pulmonary disease, SD standard deviation. aHb < 12 g/dL.

Patients' characteristics Numbers in parenthesis are standard deviation and ranges. OA osteoarthritis, RA rheumatoid arthritis, PTA post-traumatic arthritis, ASA American Society of Anesthesiologist. Preoperative data SD standard deviation, KSS Knee Society Score, KSFS Knee Society Function Score, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, TFM tibiofemoral mechanical axis, ROM range of knee motion. Prevalence of comorbidities DM diabetes mellitus, CAD coronary artery disease, CHF congestive heart failure, CVA cerebral vascular accident, COPD chronic obstructive pulmonary disease, SD standard deviation. aHb < 12 g/dL. At the latest follow-up, compared to the preoperative scores, both groups had improved in the KSS, KSFS, and WOMAC scores (p < 0.001). The tube drainage amount, wound length, length of stay, mean postoperative KSS, KSFS, WOMAC score, ROM, and TFM of the knee were all similar between two groups (Table 4).
Table 4

Intraoperative and postoperative data

Parameter≥80 years group mean (SD; range)Control group mean (SD; range) p value
Tube drainage, mL
493 (173; 201–1,015)
460 (179; 188–920)
0.429
Wound length, cm
10.3 (1.1; 7.8–13)
9.9 (0.9; 8–13)
0.107
Length of stay, day
6.1 (1.3; 5–11)
5.7 (1.2; 4–12)
0.061
KSS, points
86 (4.1; 72–92)
88 (4.1; 76–94)
0.77
KSFS, points
87 (3.8; 70–88)
89 (4.0; 78–92)
0.936
WOMAC, points
15.0 (7.9; 2–39)
14.6 (6.4; 1–35)
0.681
TFM
0.22° valgus (2.9° valgus to 2.4° varus)
0.05° varus (2.4° valgus to 2.6° varus)
0.109
ROM118° (8.7°; 95°–145°)120° (11.4°; 90°–140°)0.811

KSS Knee Society Score, KSFS Knee Society Function Score, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, TFM tibiofemoral mechanical axis, ROM range of knee motion.

Intraoperative and postoperative data KSS Knee Society Score, KSFS Knee Society Function Score, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, TFM tibiofemoral mechanical axis, ROM range of knee motion. As for postoperative complications, the ≥80 years group had a higher rate of confusion (6.7% versus 0%, p = 0.026) and a higher rate of blood transfusion (29.3% versus 10.7%, p = 0.003) than controls. After Bonferroni correction, only blood transfusion reached significant difference. Two patients in the ≥80 years group and one control developed pneumonia after surgery. One patient in the ≥80 years group needed intensive care because of respiratory failure related to pneumonia. One control had acute myocardial infarction after surgery and underwent cardiac catheterization and stenting for coronary artery stenosis. One patient in the ≥80 years group and one control developed distal DVT after surgery and were treated with low-molecular-weight heparin followed by oral vitamin-K antagonist for 3 months. One control developed distal DVT 6 weeks after surgery and treated with oral vitamin-K antagonist only for 3 months. One control with a history of PE developed recurrent PE 4 days after surgery and was transferred to the cardiology department for further treatment. One patient in the ≥80 years group had postoperative CHF because of fluid overload. Three patients in the ≥80 years group had UGI bleeding. Two of them used indomethacin by suppository and did not receive gastroprotective agents. The other one who had peptic ulcer history developed UGI bleeding 2 days after surgery. Three patients in the ≥80 years group and one control had atelectasis postoperatively and recovered after aggressive pulmonary therapy. Other postoperative complications were similar between two groups (Table 5). One octogenarian patient had a periprosthetic fracture of the distal femur after TKA and was treated with open reduction and internal fixation with a blade plate and bone grafts. No patient in either group sustained deep infection or loosening of the prosthesis. There was no 90-day mortality in either group but one patient in the ≥80 years group died from unrelated causes more than 1 year after operation.
Table 5

Number of complications within 90 days after total knee arthroplasty

Complication≥80 years groupControl group p value
Confusion, n (%)
5 (6.7%)
0 (0%)
0.026
Pneumonia, n (%)
2 (2.7%)
1 (1.3%)
0.614
MI, n (%)
0 (0%)
1 (1.3%)
0.243
DVT with positive venogram, n (%)
1 (1.3%)
2 (2.7%)
0.584
ICU care, n (%)
1 (1.3%)
1 (1.3%)
0.976
Postop CHF, n (%)
1 (1.3%)
0 (0%)
0.49
PE, n (%)
0 (0%)
1 (1.3%)
0.326
UGI bleeding, n (%)
3 (4%)
0 (0%)
0.115
Anemia, n (%)
17 (22.7%)
18 (24%)
0.959
Atelectasis, n (%)
3 (4%)
1 (1.3%)
0.359
Superficial wound infection, n (%)
4 (5.3%)
1 (1.3%)
0.203
Number of patients receiving transfusion, n (%)22 (29.3%)8 (10.7%)0.003*

MI myocardial infarction, DVT deep vein thrombosis, CHF congestive heart failure, PE pulmonary embolism, UGI upper gastrointestinal, ICU intensive care unit. *Bonferroni-adjusted significance level of 0.00416.

Number of complications within 90 days after total knee arthroplasty MI myocardial infarction, DVT deep vein thrombosis, CHF congestive heart failure, PE pulmonary embolism, UGI upper gastrointestinal, ICU intensive care unit. *Bonferroni-adjusted significance level of 0.00416.

Discussion

Our study demonstrated that the both groups had improved clinical outcomes and patient satisfaction after TKA. In a long-term-follow-up study of 100 patients who were aged ≥80 years and underwent total joint arthroplasty (70 hips, 30 knees), the satisfaction rate was high (95%), and 97% of patients maintained a degree of independent living [12]. In our study, the mean postoperative KSS and KSFS in the ≥80 years group were 86 and 87 points, respectively, similar to the mean postoperative scores in the control group (88 and 89 points, p = 0.898 and p = 0.936, respectively). With regard to satisfaction, the mean postoperative WOMAC score was also similar between the two groups (15.0 versus 14.6, p = 0.817), indicating both groups of patients were satisfied with TKA. As for the radiographic results, there were no outliers (>3° deviation from the ideal, 0°) in either group. These results may explain the high patient satisfaction rate in our series. It has been reported that the 90-day mortality rate after primary standard TKA was 0.46% [13]. Risk factors that increased the mortality after TKA included age >70 years; use of a cemented prosthesis; preexisting cardiopulmonary disease; and simultaneous bilateral arthroplasty [14]. The ≥80 years patient population had a higher risk of prevalence of comorbidities, including coronary disease and impaired myocardial function, which were related to postoperative complications and increased mortality [4]. Surgical volume is also related to short-term mortality after TKA. Lavernia and Guzman reported a significantly higher mortality rate in patients of low-volume surgeons (<10 per year) than medium- (10–100 per year) and high-volume (>100 per year) surgeons [15]. Kreder et al. [16] reported that, compared with patients aged 65 to 79 years, octogenarians carried a 3.4-time greater risk of mortality, a 3.5-time greater risk of pneumonia, and a 2.7-time greater risk of myocardial infarction after hip or knee arthroplasty. The TKA mortality rate was 1.09% in the octogenarians and 0.32% in the younger group. Our study did not find a higher 90-day mortality rate in the ≥80 years group: there were no deaths within 90 days in either group. We attribute this to the following: first, our patient sample was small; second, we selected patients with low risk through a preoperative consultation of cardiologist and neurologist; and third, we belong to a group of high-volume (>100 per year) arthroplasty surgeons. In this study, we found a higher rate of postoperative confusion (6.7% versus 0%, p = 0.026) in the ≥80 years group compared with the control group, although it was not significant after Bonferroni correction. Kreder et al. [16] reported postoperative confusion was significantly higher in the octogenarian (2.33% vs 0.68%, with an OR of 3.6). The risk factors related to postoperative confusion are advanced age and general anesthesia [17]. Most of our patients (97.3%) underwent general anesthesia (Table 1), which may contribute to the higher rate of postoperative confusion among octogenarians. Transfusion rate was greater among the ≥80 years group than the control group (29.3% versus 10.7%, p = 0003). Clement et al. [3] also reported a higher transfusion rate among octogenarians compared to the younger patients after standard TKA. However, the transfusion rate for their octogenarian patients was much lower (19.7%). We attribute this to the following reasons. First, our ≥80 years group had low mean preoperative levels of Hb and Hct, although they did not reach statistical significances (Table 3). Additionally, according to our hospital policy, a minimum Hb level of 10 g/dL is mandatory before any major operation, including TKA (4 patients aged ≥80 years and 1 younger patient had preoperative Hb ≤ 10 g/dL). Second, postoperative UGI bleeding was more frequent in the ≥80 years group than in the controls (4% versus 0%). This may have contributed to their higher rate of transfusion. There was 4% rate (3 patients) of postoperative UGI bleeding in the ≥80 years group although it was not significantly different. Two patients used indomethacin by suppository post-operatively and did not receive gastroprotective agents. The other one had peptic ulcer history. After this study, we used gastroprotective agents such as proton pump inhibitors routinely in patients with history of peptic ulcer or in all patients who receive indomethacin for pain relief postoperatively. We acknowledge the limitations of this study. It was a retrospective design, but we utilized a matched case-controlled study design to ensure that we accounted for potentially confounding risk factors as possible. It would be difficult or impossible to randomize the patients aged ≥80 years or older to a group that did or did not receive preoperative consultation. However, for the safety of elderly patients and to avoid unexpected postoperative complications, it has become our routine protocol for all patients aged ≥80 years and younger patients with history of cardiovascular or cerebrovascular events undergoing major orthopedic surgery.

Conclusion

Our study showed that TKA was an effective procedure for patients aged 80 years or more. However, the ≥80 years group had a higher complication rate of blood transfusion compared with the younger patient group. With a preoperative evaluation by cardiologists and neurologists, patients aged 80 years or older have a low postoperative cardiovascular or cerebrovascular complications and 90-day mortality after TKA.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

FCK conceived of the study, participated in the study design, and drafted the manuscript. CHH performed the statistical analysis. WSC participated in the data acquisition and helped in drafting the manuscript. JWW performed the final approval of the version to be submitted. All authors read and approved the final manuscript.
  17 in total

1.  Thirty-day mortality after total knee arthroplasty.

Authors:  J Parvizi; T A Sullivan; R T Trousdale; D G Lewallen
Journal:  J Bone Joint Surg Am       Date:  2001-08       Impact factor: 5.284

2.  Prevention of deep-vein thrombosis after total knee arthroplasty in Asian patients. Comparison of low-molecular-weight heparin and indomethacin.

Authors:  Ching-Jen Wang; Jun-Wen Wang; Lin-Hsiu Weng; Chia-Chen Hsu; Chung-Cheng Huang; Pao-Chu Yu
Journal:  J Bone Joint Surg Am       Date:  2004-01       Impact factor: 5.284

3.  Arthroplasty in the octogenarian: quantifying the risks.

Authors:  Hans J Kreder; Gregory K Berry; Ian A McMurtry; Stephen I Halman
Journal:  J Arthroplasty       Date:  2005-04       Impact factor: 4.757

4.  Early mobilisation after conventional knee replacement may reduce the risk of postoperative venous thromboembolism.

Authors:  E O Pearse; B F Caldwell; R J Lockwood; J Hollard
Journal:  J Bone Joint Surg Br       Date:  2007-03

Review 5.  2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery.

Authors:  Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliot L Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy R Kersten; Barbara Riegel; John F Robb
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094

6.  The outcome of primary total hip and knee arthroplasty in patients aged 80 years or more.

Authors:  N D Clement; D MacDonald; C R Howie; L C Biant
Journal:  J Bone Joint Surg Br       Date:  2011-09

7.  [Influence of general anesthetics on the incidence of postoperative delirium in the elderly].

Authors:  Koji Ishii; Daiji Akiyama; Katsumi Hara; Tetsuji Makita; Koji Sumikawa
Journal:  Masui       Date:  2011-07

8.  Health-related quality of life after total knee or hip replacement for osteoarthritis: a 7-year prospective study.

Authors:  O Bruyère; O Ethgen; A Neuprez; B Zégels; Ph Gillet; J-P Huskin; J-Y Reginster
Journal:  Arch Orthop Trauma Surg       Date:  2012-07-28       Impact factor: 3.067

Review 9.  The preoperative cerebrovascular consultation: common cerebrovascular questions before general or cardiac surgery.

Authors:  David J Blacker; Kelly D Flemming; Michael J Link; Robert D Brown
Journal:  Mayo Clin Proc       Date:  2004-02       Impact factor: 7.616

10.  Risk of ischemic stroke in patients with symptomatic vertebrobasilar stenosis undergoing surgical procedures.

Authors:  David J Blacker; Kelly D Flemming; Eelco F M Wijdicks
Journal:  Stroke       Date:  2003-10-02       Impact factor: 7.914

View more
  9 in total

1.  Preoperative body mass index and physical function are associated with length of stay and facility discharge after total knee arthroplasty.

Authors:  Matthew G Prohaska; Benjamin J Keeney; Haaris A Beg; Ishaan Swarup; Wayne E Moschetti; Stephen R Kantor; Ivan M Tomek
Journal:  Knee       Date:  2017-03-20       Impact factor: 2.199

2.  The benefits of computer-assisted total knee arthroplasty on coronal alignment with marked femoral bowing in Asian patients.

Authors:  Chien-Yin Lee; Shih-Jie Lin; Liang-Tseng Kuo; Kuo-Ti Peng; Kuo-Chin Huang; Tsan-Wen Huang; Mel S Lee; Robert Wen-Wei Hsu; Wun-Jer Shen
Journal:  J Orthop Surg Res       Date:  2014-12-03       Impact factor: 2.359

Review 3.  The effects of advanced age on primary total knee arthroplasty: a meta-analysis and systematic review.

Authors:  Ethan F Kuperman; Marin Schweizer; Parijat Joy; Xiaomei Gu; Michele M Fang
Journal:  BMC Geriatr       Date:  2016-02-10       Impact factor: 3.921

4.  PROFILE OF PATIENTS RECEIVING TOTAL KNEE ARTHROPLASTY: A CROSS-SECTIONAL STUDY.

Authors:  Marcelo José Cortez Bezerra; Igor Magalhães Barbosa; Thales Gonçalves DE Sousa; Larissa Meireles Fernandes; Diego Leonardo Menezes Maia; Lucas Meireles Holanda
Journal:  Acta Ortop Bras       Date:  2017 Sep-Oct       Impact factor: 0.513

5.  AQUACEL® Ag Surgical Dressing Reduces Surgical Site Infection and Improves Patient Satisfaction in Minimally Invasive Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.

Authors:  Feng-Chih Kuo; Bradley Chen; Mel S Lee; Shih-Hsiang Yen; Jun-Wen Wang
Journal:  Biomed Res Int       Date:  2017-08-02       Impact factor: 3.411

6.  The Effect of Comorbidities and Age on Functional Outcomes After Total Knee Arthroplasty in the Octogenarian: A Matched Cohort Study.

Authors:  Eric Wei Liang Cher; Kae Sian Tay; Karen Zhang; Seang Beng Tan; Tet Sen Howe; Joyce Suang Bee Koh
Journal:  Geriatr Orthop Surg Rehabil       Date:  2018-05-16

7.  Total knee arthroplasty in Japanese patients aged 80 years or older.

Authors:  Shunsuke Kodaira; Tadashi Kikuchi; Michiyuki Hakozaki; Shinichi Konno
Journal:  Clin Interv Aging       Date:  2019-04-15       Impact factor: 4.458

8.  Comparison of Effects of a Thrombin-Based Hemostatic Agent and Topical Tranexamic Acid on Blood Loss in Patients with Preexisting Thromboembolic Risk Undergoing a Minimally Invasive Total Knee Arthroplasty. A Prospective Randomized Controlled Trial.

Authors:  Shih-Hsiang Yen; Po-Chun Lin; Cheng-Ta Wu; Jun-Wen Wang
Journal:  Biomed Res Int       Date:  2021-01-14       Impact factor: 3.411

9.  Improved femoral component rotation in advanced genu valgum deformity using computer-assisted measured resection total knee arthroplasty.

Authors:  Shih-Jie Lin; Chien-Ying Lee; Kuo-Chin Huang; Kuo-Ti Peng; Tsan-Wen Huang; Mel S Lee; Robert Wen-Wei Hsu; Wun-Jer Shen
Journal:  J Orthop Surg Res       Date:  2015-09-02       Impact factor: 2.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.